P. Connor Johnson
Articles
-
May 4, 2023 |
oncologytube.com | P. Connor Johnson |Connor Johnson
Polatuzumab Vedotin: How can the POLARIX trial help us comprehend DLBCL? Connor Johnson MDBy P. Connor Johnson, MDMy name is Connor Johnson, and I am the medical oncologist at the Center for Lymphoma in the Massachusetts General Hospital Cancer Center. It is my privilege today to discuss the POLARIX trial, which potentially changes the standard of care for the treatment of diffuse large B-cell lymphoma, the most common lymphoma.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →